000 03399nam a2200445 i 4500
999 _c393907
_d393907
001 393907
003 ES-MaUEC
005 20230102123035.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 220905s2022 sz a o |||| 0|eng d
020 _a9783031002410
024 7 _a10.1007/978-3-031-00241-0
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRM275
_b2022 EB
245 0 0 _aManaging Immunotherapy Related Organ Toxicities :
_bA Practical Guide
_cedited by Yinghong Wang
250 _a1st edition 2022
264 1 _aCham
_bSpringer International Publishing
_c2022
300 _a1 recurso en línea (XX, 322 páginas)
_b29 ilustraciones, 26 ilustraciones a color
336 _atexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
505 0 _aEndocrine toxicity -- Gastrointestinal toxicity -- Heart toxicity -- Kidney toxicity -- Liver toxicity -- Lung toxicity -- Muscular -- skeletal toxicity -- Neuro toxicity -- Pancreas toxicity -- Skin toxicity -- Emergency/Inpatient/Outpatient Workflow.
520 _aCertain organ toxicities can be severe and life-threatening. Therefore, it is crucial to recognize these disease entities early on to provide prompt and effective treatments to improve the quality of patient care, and enable the continuation of cancer therapy long-term. A clinical handbook with a particular focus in this field is lacking. This handbook focuses on the comprehensive, systematic review of clinical aspects of immunotherapy-induced toxicities in 15 major organ systems. The organs covered include endocrine, eye, gut, heart, kidney, liver, lung, muscular-skeletal, neuro, pancreas and skin etc. A unique feature about this book is the inclusion of perspectives from Anesthesiology, Infectious Disease, and Pathology besides specific organ toxicity management. The contributors are a group of experts offering routine clinical care to patients with most complex and refractory toxicity conditions, conducting pioneering research, and providing the guidance for the clinical practice to the peers and trainees in the field. The topics of each chapter include incidence, clinical presentations, evaluation, management, and long term follow up of each disease entity. There is also a simplified management algorithm or table illustrated in each chapter as well as audio PowerPoint slide deck to provide straightforward general instruction on the evaluation and treatment.
988 _aSpringer_Medicine_2022
650 7 _2embne
_9145440
_aInmunoterapia
_xComplicaciones
650 7 _2embne
_9174085
_aCáncer
_xTratamiento
_xComplicaciones
700 1 _aWang, Yinghong
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
776 0 8 _iPrinted edition:
_z9783031002403
776 0 8 _iPrinted edition:
_z9783031002427
776 0 8 _iPrinted edition:
_z9783031035043
776 0 8 _iPrinted edition:
_z9783031035050
776 0 8 _iPrinted edition:
_z9783031035067
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-031-00241-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b12/2022
_dz
_eb
_zSI